🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Nano-X Imaging Ltd. NNOX R2K

Healthcare · Medical Devices · Israel
https://www.nanox.vision

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence–based solution; AI-Based Body Composition Measurement, an artificial intelligence–based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.

READ MORE ›
$1.92
-62.50% 1Y

Market & Price

Market Cap
$133.61M
Current Price
$1.92
High / Low (52W)
$5.63 / $1.63
Beta
1.18

Valuation

Stock P/E
-
Industry PE
23.65
Forward P/E
-
PEG Ratio
-
Book Value
$2.01
Price to Book
0.96
P/S
10.26
EV/EBITDA
-1.67
Dividend Yield
-

Profitability & Returns

ROCE
-41.78%
ROE
-45.62%
ROA
-20.37%
Profit Margin
0.00%
Op Margin
-
EPS (Latest Qtr)
$-0.50
EPS (TTM)
$-1.16

Balance Sheet & Liquidity

Debt/Equity
0.06
Quick Ratio
3.65
Current Ratio
3.96
Debt
$7.85M
Total Assets
$162.16M
Current Assets
$66.79M
Working Capital
$49.91M

Ownership

Promoter Holding
0.35%
Chg in Prom Hold
-
FII / Inst Holding
27.02%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
$81.85M
Total Revenue (TTM)
$13.02M
EBITDA
$-48.95M
Free Cash Flow
$-25.29M
Operating Cash Flow
$-40.79M
Shares Outstanding
69.59M
Gross Margin
-98.21%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
14.93%
Profit 5Y
11.25%
Revenue (YoY)
24.00%
Earnings (YoY)
-

PROS

  • Compounding revenue at 14.9% over 5 years.
  • Profit CAGR of 11.3% over 5 years.

CONS

  • Trading 65.9% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 NNOX Nano-X Imaging Ltd. R2K 1.92 - $133.61M - -41.78% -45.62% 14.93% 11.25%
2 LLY Eli Lilly and Company SPX 1,105.00 39.21 $985.37B 0.63% 38.44% 107.46% 31.69% 48.96%
3 JNJ Johnson & Johnson SPX 225.33 26.11 $542.42B 2.38% 23.13% 26.42% 5.60% 14.32%
4 UNH UnitedHealth Group Incorporated SPX 380.31 28.66 $345.38B 2.32% 9.60% 12.18% 11.35% -15.69%
5 MRK Merck & Co., Inc. SPX 118.72 33.44 $293.22B 2.86% 20.66% 18.94% 3.12% 7.93%
6 TMO Thermo Fisher Scientific Inc. SPX 492.51 27.11 $183.03B 0.38% 9.17% 13.52% -0.27% -1.19%
7 AMGN Amgen Inc. NDXSPX 336.79 23.42 $181.77B 2.99% 18.02% 101.32% 11.77% 5.58%
8 GILD Gilead Sciences, Inc. NDXSPX 134.43 18.29 $166.90B 2.44% 22.92% 43.36% 2.57% 22.83%
9 ISRG Intuitive Surgical, Inc. NDXSPXAI 424.64 51.53 $150.39B - 15.96% 17.23% 17.39% 29.26%
Ad space

Quarterly Results

Figures in USD.

Metric Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue -3.00M2.81M3.04M3.45M3.72M
Cost of Revenue -5.89M5.86M6.28M6.33M7.34M
Gross Profit --2.89M-3.05M-3.24M-2.88M-3.62M
Operating Expenses -12.09M11.04M11.25M11.35M14.27M
Operating Income --14.97M-14.09M-14.49M-14.23M-17.88M
EBITDA --12.04M-11.15M-11.54M-11.28M-15.04M
Interest Expense ---149.00K--
Pretax Income --14.15M-13.32M-14.64M-13.78M-35.07M
Tax Provision --94.00K-86.00K82.00K-94.00K-1.69M
Net Income --14.06M-13.24M-14.72M-13.68M-33.37M
Diluted EPS --0.23-0.21-0.23-0.21-0.50

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -8.58M9.90M11.28M13.02M
Cost of Revenue -15.46M16.50M21.89M25.81M
Gross Profit --6.88M-6.59M-10.61M-12.79M
Operating Expenses -80.33M53.06M46.14M47.91M
Operating Income --87.21M-59.66M-56.75M-60.70M
EBITDA --75.70M-47.85M-45.01M-49.00M
Interest Expense -----
Pretax Income --116.92M-61.12M-53.87M-76.81M
Tax Provision --3.68M-339.00K-358.00K-1.79M
Net Income --113.24M-60.78M-53.52M-75.02M
Diluted EPS --2.01-1.08-0.91-1.16

Compounded Sales Growth

5 Years:14.93%
1 Year:24.00%

Compounded Profit Growth

5 Years:11.25%
1 Year:-

Stock Price Performance

1 Year:-62.50%
6 Months:-57.52%
3 Months:-18.99%
1 Month:+12.28%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets -253.93M218.65M210.00M162.16M
Current Assets -82.46M88.64M78.68M66.79M
Cash & Equivalents -38.46M56.38M39.30M49.15M
Inventory -02.36M1.49M3.07M
Receivables -977.00K1.48M1.80M2.01M
Total Liabilities -37.25M23.13M20.88M22.43M
Current Liabilities -25.07M15.52M13.97M16.89M
Long Term Debt 3.80M3.48M---
Total Debt -4.62M8.40M7.45M7.85M
Total Equity -216.68M195.51M189.12M139.73M
Shares Outstanding -55.09M57.78M63.76M69.59M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow --43.38M-44.78M-36.60M-40.79M
Investing Cash Flow -14.61M35.43M-20.05M29.37M
Financing Cash Flow -804.00K27.25M39.50M21.37M
Capital Expenditure --7.17M-3.30M-2.77M-4.21M
Free Cash Flow --50.56M-48.08M-39.37M-45.00M
Net Change in Cash --27.98M17.91M-17.14M9.95M

Ratios (Annual)

Figures in %.

Metric Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % --80.2%-66.6%-94.0%-98.2%
Operating Margin % --1,016.6%-602.3%-502.9%-466.2%
Net Margin % --1,320.2%-613.6%-474.3%-576.1%
ROE % --52.3%-31.1%-28.3%-53.7%
ROCE % --38.1%-29.4%-28.9%-41.8%

Shareholding Pattern

Insiders
0.35%
Institutions
27.02%
Public Float
27.11%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 5.49% 3.82M $7.33M
2 Weiss Asset Management Lp 4.01% 2.79M $5.36M
3 UBS Group AG 1.94% 1.35M $2.59M
4 State Street Corporation 1.75% 1.22M $2.34M
5 Geode Capital Management, LLC 1.28% 893.10K $1.71M
6 ARK Investment Management, LLC 1.05% 733.29K $1.41M
7 National Bank of Canada/FI/ 0.82% 573.03K $1.10M
8 Northern Trust Corporation 0.75% 524.29K $1.01M
9 AQR Capital Management, LLC 0.71% 494.69K $949.81K
10 Bank of America Corporation 0.70% 484.33K $929.91K

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for NNOX

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks